SCHEMBL7143033

SCHEMBL7143033

CC(=O)c1ccccc1OCc1cccc(S(N)(=O)=O)c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.49
KMT2A Q03164 3/20 0.49
SMN1; SMN2 Q16637 3/20 0.47
LMNA P02545 3/20 0.47
ALDH1A1 P00352 2/20 0.47
KDM4E B2RXH2 1/20 0.47
POLB P06746 2/20 0.47
MAOB P27338 2/20 0.46
MAPT P10636 1/20 0.46
CYP2C9 P11712 1/20 0.46
CYP2C19 P33261 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
SGMS2 Q8NHU3 1/20 0.45
CA1 P00915 1/20 0.45
CA2 P00918 1/20 0.45
CA9 Q16790 1/20 0.45
HTT P42858 1/20 0.44
PARP1 P09874 2/20 0.44
PARP2 Q9UGN5 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14372385 0.80 SGMS2 (0.69) MEN1KMT2ASMN1; SMN2ALDH1A1MAPT
SCHEMBL15887756 0.80 MEN1 (0.62) MEN1KMT2ASMN1; SMN2LMNAALDH1A1
SCHEMBL71081 0.79 SGMS2 (0.67) MEN1KMT2ASMN1; SMN2LMNAALDH1A1
SCHEMBL30468871 0.79 SGMS2 (0.67) MEN1KMT2ASMN1; SMN2LMNAALDH1A1
SCHEMBL13348916 0.77 MRGPRX4 (0.71) MEN1KMT2ASMN1; SMN2
SCHEMBL10178559 0.76 MEN1 (0.48) MEN1KMT2ASMN1; SMN2LMNAALDH1A1
SCHEMBL6960295 0.75 RAB9A (0.58) MEN1KMT2ASMN1; SMN2LMNAALDH1A1
SCHEMBL7142951 0.75 NLRP3 (0.57)
SCHEMBL8277221 0.73 GAA (0.62) MEN1KMT2ASMN1; SMN2LMNAALDH1A1
SCHEMBL3148800 0.73 L3MBTL1 (0.56) MEN1KMT2ASMN1; SMN2LMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1127479-C Sulfonylurea derivatives and their use in the control of interleukin-1 activity PFIZER (US) 2003-11-12 CN disclosed
EP-0964849-B1 SULFONYL UREA DERIVATIVES AND THEIR USE IN THE CONTROL OF INTERLEUKIN-1 ACTIVITY PFIZER (US) 2003-06-04 EP disclosed
EP-1270554-A1 Sulfonyl urea derivatives and their use in the control of interleukin-1 activity PFIZER INC. (US) 2003-01-02 EP disclosed
EP-1270565-A1 4-Substituted furan-2-sulfonamide and its use in the preparation of sulfonyl urea derivatives PFIZER INC. (US) 2003-01-02 EP disclosed
US-6433009-B1 TREATMENT OF AUTOIMMUNE, CARDIOVASCULAR, NERVOUS SYSTEM, GASTROINTESTINAL, RESPIRATORY SYSTEM, AND VIRAL DISORDERS; ANTIDIABETIC, ANTIARTHRITIC, ANTIINFLAMMATORY AND ANTIDEPRESSANT AGENTS PFIZER INC 2002-08-13 US disclosed
US-6166064-A Sulfonyl urea derivatives and their use in the control of interleukin-1 activity PFIZER INC (US) 2000-12-26 US disclosed
CN-1245490-A Sulfonyl urea derivatives and their use in control of interleukin-1 activity PFIZER (US) 2000-02-23 CN disclosed
EP-0964849-A1 SULFONYL UREA DERIVATIVES AND THEIR USE IN THE CONTROL OF INTERLEUKIN-1 ACTIVITY PFIZER INC. (US) 1999-12-22 EP disclosed
WO-1998032733-A1 SULFONYL UREA DERIVATIVES AND THEIR USE IN THE CONTROL OF INTERLEUKIN-1 ACTIVITY PFIZER INC. (US) 1998-07-30 WO disclosed